While medicinal inorganic chemistry has been practised for over 5000 years, it was not until
the late 1800s when Alfred Werner published his ground-breaking research on coordination …

A novel strategy in metallodrug discovery today is incorporating clinically approved drugs
into metal complexes as coordinating ligands. Using this strategy, various drugs have been …

Hydroxyquinolines are heterocyclic compounds characterized by a moderate metal-binding
affinity. The interest in 8-hydroxyquinolines has grown exponentially in the last two decades …

The small molecule anticancer agent cisplatin and its Pt (II) analogs carboplatin and
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …

8-Hydroxyquinoline and its derivatives have a broad variety of pharmacological properties,
which make them an ideal bioactive building block in the development of metal-based …

Quinoline-based metal complexes have gained considerable attention in recent years due
to their applications in various fields, including catalysis, material sciences, and medicinal …

Twenty new zinc (II) complexes with 8-hydroxyquinoline (H-Q1–H-Q6) in the presence of 1,
10-phenanthroline derivatives (D1–D10) were synthesized and formulated as [Zn (Q1) 2 …

In the quest for rare earth metal complexes with enhanced cancer chemotherapeutic
properties, the discovery of seven lanthanide (III) complexes bearing 8-hydroxyquinoline-N …

A series of organoruthenium (II) chlorido complexes with fluorinated O, O-ligands [(η6-p-
cymene) Ru (F3C-acac-Ar) Cl](1a–6a) and their respective 1, 3, 5-triaza-7 …

Abstract Two platinum (II) complexes,[Pt (ClQ)(DMSO) Cl](ClQ-Pt) and [Pt (BrQ)(DMSO)
Cl](BrQ-Pt), with 5, 7-dichloro-2-methyl-8-quinolinol (H-ClQ) and 5, 7-dibromo-2-methyl-8 …